Skip to main content
European Innovation Council
Story 20 January 2022

Open Call: Pitch your biotech solutions at BIO 2022 with the EIC OTF Programme 2.0

Eirini Sotiropoulou

The EIC Overseas Trade Fairs (OTF) Programme 2.0 invites you to submit your application for the BIO International Convention 2022. The world's largest gathering of leading professionals in the biotechnology industry will take place from 13 to 16 June 2022 in San Diego, USA. 


BIO 2022 represents more than 1,100 biotechnology companies, academic institutions, biotechnology centres and related organisations across the United States and in more than 30 countries. It brings together a wide spectrum of life science and application, including drug discovery, biomanufacturing, genomics, biofuels, nanotechnology, and cell therapy.

The agenda of the prestigious tradeshow entails many interactive sessions and unparalleled networking opportunities with 16,000+ attendees from 67 countries. BIO combines world premieres and live demonstrations of products spanning the entire value chain with exciting business partnerships. Interested in showcasing your outstanding solutions and establish high level contacts overseas?


Applications are open until 28th January 2022 


What’s in it for you?

EIC-funded SMEs, start-ups and scale-ups, who will be selected to attend BIO 2022, will have access to unique business services, including pitching, matchmaking support, a free booth to exhibit their innovations within the European Pavilion, mentoring services, and the reimbursement of 50% of all expenses up to EUR 1 000.

Who can apply?

BIO 2022 is looking for EIC-funded SMEs, start-ups and scale-ups working on cutting-edge innovations in the following fields: 

  • BIOEquality - Diversity, Equity and Inclusion in Biotech
  • Biomanufacturing
  • Brain Health
  • Cell and Gene Therapies/Genome Editing
  • Chronic Diseases
  • Clinical Trials
  • Diagnostics and Personalized Medicine
  • Digital Health
  • Next Generation Biotherapeutics
  • Oncology
  • Patient Advocacy
  • Rare Diseases


You can apply by clicking on the following link: BIO 2022 participation

After logging in with your EU-Login, please fill in the corresponding form and answer all the questions.  

You will be assessed on the following criteria:

  • Your plan to internationalise your innovative products and services overseas.
  • The expected impact of your participation to the trade fair.
  • The fit of your products and services with the trade fair.
  • Your commitment of financial and human resources for participation to a trade fair. 

Please notice that the information you provide on the application form will be shared with external experts in order to maximise potential benefits and ensure the effectiveness of meetings. 

The OTF team will then contact all applicants once the selection process has been concluded, and inform each applicant of the outcome of their application. 


About the EIC Overseas Trade Fairs Programme 2.0 

The EIC Overseas Trade Fairs (OTF) Programme 2.0 supports EIC beneficiaries to promote their commercialisation strategy in foreign markets and leverage business opportunities at the most popular trade fairs, strengthening the EU innovation brand around the world. Selected EIC-funded SMEs, start-ups and scale-ups from EU Member States and associated countries will have access to the Programme.

The EIC OTF Programme 2.0 is running throughout 2022 and 2023, offering EIC beneficiaries the opportunity to attend 15 international trade fairs in different sectors across four extra-EU markets (China, Southeast Asia, the United Arab Emirates and the United States of America).

Should you have any question, please contact us through the EIC Community Helpdesk (please select the category “EVENT – EIC OTF Programme – BIO’’ as the subject).


Cancellation policy

Cancellations will only be considered in duly documented cases of “force majeure”. Unjustified cancellation can lead to exclusion in future EIC Business Acceleration Services initiatives. 

DISCLAIMER: This information is provided in the interest of knowledge sharing and should not be interpreted as the official view of the European Commission, or any other organisation.

Please log in to see comments and contribute